GPC Biotech, Inc.


Aug 23, 07

NEW STORY
01:58 ET GPC Biotech Announces Restructuring

 
Aug 08, 07

01:37 ET GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2007

 
Jul 30, 07

09:57 ET GPC Biotech Withdraws Satraplatin NDA Filed for Accelerated Approval

 
Jul 27, 07

14:05 ET GPC Biotech AG Named in Purported Class Action Lawsuit in the United States

 
Jul 24, 07

19:41 ET FDA Oncologic Drugs Advisory Committee Recommends that FDA Wait for Overall Survival Results from Satraplatin Phase 3 Trial

 
Jul 20, 07

08:59 ET GPC Biotech Schedules Conference Call on July 25 to Discuss Oncologic Drugs Advisory Committee (ODAC) Recommendation on Satraplatin

 
Jun 26, 07

02:41 ET GPC Biotech Announces that Partner Pharmion Submits European Marketing Application for Satraplatin

 
Jun 25, 07

02:36 ET GPC Biotech Announces Partnering Agreement for Satraplatin for Japan with Yakult

 
Jun 14, 07

10:13 ET GPC Biotech to Present at Second Annual Piper Jaffray London Health Care Conference

 
Jun 08, 07

10:30 ET GPC Biotech to Present at Two Upcoming Conferences: Goldman Sachs 28th Annual Global Healthcare Conference in California and 6th Annual Needham Biotechnology & Medical Technology Conference in New York

 
Jun 04, 07

10:43 ET Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting

 
May 29, 07

11:46 ET GPC Biotech to Host Investor Event in Chicago on June 4th during ASCO Annual Meeting

 
May 25, 07

09:32 ET GPC Biotech Announces Election of Donald Soltysiak to Supervisory Board

 
May 21, 07

16:00 ET Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association

 
May 15, 07

01:45 ET GPC Biotech Reports Financial Results for the First Quarter of 2007

 
01:43 ET GPC Biotech's Satraplatin NDA to be Reviewed by ODAC Panel on July 24, 2007

 
May 09, 07

04:01 ET GPC Biotech to Present at Two Upcoming Conferences: Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference in Monte Carlo and Citigroup Healthcare Conference in New York City

 
May 07, 07

05:20 ET GPC Biotech Schedules Conference Call on May 15th to Discuss First Quarter 2007 Financial Results

 
May 03, 07

10:49 ET GPC Biotech Consolidates Drug Discovery Activities

 
Apr 16, 07

01:31 ET FDA Accepts GPC Biotech's Satraplatin NDA for Filing and Grants Priority Review Status

 
Mar 22, 07

05:54 ET Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress

 
Mar 16, 07

08:34 ET GPC Biotech to Present at Lehman Brothers Tenth Annual Global Healthcare Conference in Florida

 
Mar 15, 07

02:39 ET GPC Biotech Reports Financial Results for Fiscal Year 2006

 
Mar 09, 07

05:11 ET GPC Biotech Meeting and Conference Call on Business Results for the Fiscal Year 2006 Scheduled for March 15

 
Feb 23, 07

07:15 ET Satraplatin Shown to Significantly Reduce Risk of Disease Progression in Advanced Hormone-Refractory Prostate Cancer Patients

 
Feb 21, 07

04:20 ET GPC Biotech Launches Expanded Access Program for Oncology Drug Candidate Satraplatin in the U.S.

 
Feb 16, 07

02:07 ET GPC Biotech Submits NDA for Lead Oncology Drug Candidate Satraplatin

 
Jan 24, 07

06:14 ET GPC Biotech Raises Euro 33.6 Million (~$43.7) in Private Placement

 
01:31 ET Ad Hoc Announcement: GPC Biotech Announces Share Capital Issuance of up to 1,564,587 Shares

 
Dec 13, 06

01:32 ET GPC Biotech Responds to Arbitration Claim by Spectrum Pharmaceuticals

 
Dec 11, 06

04:11 ET GPC Biotech Presents Preliminary Clinical Data on Anticancer Monoclonal Antibody 1D09C3 at ASH

 
Nov 09, 06

01:41 ET GPC Biotech Reports Financial Results for Third Quarter and First Nine Months of 2006

 
Nov 02, 06

08:31 ET GPC Biotech Meeting and Conference Call on Results for the Third Quarter and First Nine Months of 2006 Scheduled for November 9th

 
Oct 30, 06

10:21 ET GPC Biotech to Present at Two Upcoming Conferences: Rodman & Renshaw Annual Healthcare Conference in New York and Cowen & Co. Global Health Care Conference in London

 
Sep 25, 06

12:22 ET GPC Biotech to Present at UBS Global Life Sciences Conference in New York City

 
04:04 ET GPC Biotech Schedules Conference Call for Today, Monday, September 25 to Discuss Positive Results from the Satraplatin Pivotal Phase 3 Trial

 
Sep 24, 06

18:49 ET GPC Biotech and Pharmion Announce Positive Results from the Satraplatin Pivotal Phase 3 Trial and Achievement of the Progression-Free Survival Endpoint

 
Aug 08, 06

01:38 ET GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2006

 
Aug 02, 06

04:52 ET GPC Biotech Initiates Phase 2 Randomized Trial Evaluating Satraplatin plus Tarceva(R) in Patients with Advanced Non-Small Cell Lung Cancer

 
Jul 12, 06

04:42 ET GPC Biotech Submits Non-Clinical Section of Rolling NDA for Lead Oncology Drug Candidate Satraplatin

 
Jun 08, 06

02:29 ET Independent Data Monitoring Board Recommends that Satraplatin Phase 3 Trial Continue as Planned

 
Jun 06, 06

04:25 ET GPC Biotech Presents New Satraplatin Clinical Data from Two Pharmacokinetics Studies at ASCO

 
Jun 02, 06

04:32 ET GPC Biotech to Present at Three Conferences in the U.S. in June

 
May 17, 06

14:34 ET Independent Data Monitoring Board Recommends Expedited Interim Analysis of Overall Survival Data for Satraplatin Phase 3 Trial

 
May 16, 06

03:14 ET GPC Biotech Announces Start of Phase 1 Trial Evaluating Satraplatin plus Xeloda(R) in Patients with Advanced Solid Tumors

 
May 08, 06

10:07 ET GPC Biotech to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference

 
May 04, 06

01:43 ET GPC Biotech Reports Financial Results for First Quarter of 2006

 
Apr 25, 06

16:25 ET Independent Data Monitoring Board Recommends that GPC Biotech Continue Satraplatin Phase 3 Trial as Planned

 
Apr 19, 06

04:34 ET GPC Biotech Expands Drug Development and Commercialization Management Teams with Three New Senior Executives

 
Apr 03, 06

04:12 ET GPC Biotech Presents New Satraplatin Pre-clinical Data at AACR

 
Mar 15, 06

01:54 ET GPC Biotech Reports Financial Results for Fiscal Year 2005

 
Feb 28, 06

05:06 ET GPC Biotech to Present at Two Upcoming Conferences in the U.S.

 
Feb 27, 06

04:01 ET GPC Biotech Presents New Satraplatin Clinical Data From Pharmacokinetics Study at ASCO Prostate Cancer Symposium

 
Feb 23, 06

19:08 ET GPC Biotech Raises 36.2 Million Euros in Private Placement with SAP Co-Founder Dietmar Hopp

 
Dec 20, 05

05:38 ET GPC Biotech Schedules Conference Call for Today, December 20th to Discuss Partnering Agreement with Pharmion Corporation for Satraplatin

 
01:09 ET GPC Biotech and Pharmion Corporation Announce Partnering Agreement for Satraplatin

 
Nov 03, 05

01:39 ET GPC Biotech Reports Financial Results for Third Quarter and First Nine Months of 2005

 
Sep 01, 05

04:53 ET GPC Biotech to Present at BioCentury's 12th NewsMakers in the Biotech Industry Investment Conference in New York City

 
Aug 04, 05

01:41 ET GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2005

 
Jul 05, 05

04:09 ET GPC Biotech Announces Phase 1 Trial Evaluating Satraplatin in Combination with TAXOTERE(R) in Patients with Advanced Solid Tumors Opens for Accrual

 
Jun 10, 05

03:54 ET GPC Biotech Presents New Pre-Clinical Data on 1D09C3 Monoclonal Cancer Antibody at the 9th International Conference on Malignant Lymphoma

 
Jun 09, 05

10:07 ET GPC Biotech to Present at Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference in California

 
Jun 02, 05

03:24 ET European Regulatory Committee Recommends Orphan Drug Status for GPC Biotech's Anticancer Monoclonal Antibody 1D09C3 for Hodgkin's Lymphoma

 
Jun 01, 05

09:37 ET GPC Biotech to Present at Pacific Growth Equities Life Sciences Growth Conference in San Francisco

 
May 30, 05

08:21 ET GPC Biotech to Present at 8th German Corporate Conference in Frankfurt

 
May 18, 05

10:15 ET GPC Biotech to Present at Fourth Annual Needham Biotechnology Conference in New York City

 
May 04, 05

02:16 ET GPC Biotech Reports Financial Results for First Quarter of 2005

 
Apr 28, 05

10:00 ET GPC Biotech to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference in Paris

 
Apr 26, 05

05:33 ET GPC Biotech and Ingenium Receive EUR 2.2 Million Joint Drug Discovery Grant from German Ministry

 
Apr 19, 05

02:42 ET Independent Data Monitoring Board Holds Second Review of Safety Data and Recommends Satraplatin Phase 3 Trial Continue as Planned

 
Apr 18, 05

03:43 ET GPC Biotech Presents New Satraplatin Data at AACR

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2007 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.